Free

Uncover the Secrets of Biotech Stocks Investment

Event Information

Share this event

Date and Time

Location

Location

E51, MIT Campus

70 Memorial Drive

Cambridge, MA 02142

View Map

Friends Who Are Going
Event description

Description

Which stock turns $10,000 into $33,800 within one year? -- Alnylam !

Which stock turns $10,000 into $154,980 within five years? -- Acadia !

Without doubt Pharmaceutical or Biotech sector have the potential for such high returns. Admittedly such stocks are highly volatile: a stock can rise 10 times in a day, and might pull back 90% the next day.

The complexity of the healthcare system and R&D progress are intimidating to most investors. Biotech companies are highly technical in their fundamentals, and their regulatory regimes are cumbersome and complex.

Boston Chinese Investments Club (BCIC) invites two seasoned Biotech investment professionals: Jingsong Xu, the founder of Growth Vision Asset Management, and Roger Song, an Equity Research Associate with a well-known investment bank on Wall Street Biopharmaceutical and medical devices industries. Together, they will uncover the secret of Biotech stocks investment.


Location: 70 Memorial Drive (MIT E51), Cambridge, MA 02142(Room number will notified once you are signed up)

Language: English

RSVP Required.


Speaker Bio

Jingsong Xu, Ph.D.

Jingsong Xu is the Founder and Portfolio Manager of Growth Vision Asset Management (“GVAM”), an investment advisory firm that focuses on clinical-stage, small to mid-sized public traded biotech companies. The company has historically delivered an annualized IRR of 34.78% over 69 months and also manages separate accounts for high-net worth individuals.

Before GVAM, Jingsong founded BioEssence Consulting, providing investment evaluation for hedge funds and venture capital firms, and worked at Brigham and Women’s Hospital at Harvard Medical School as Assistant Professor and Instructor.

Jingsong Xu graduated from Fudan University with a B.S. in Molecular Genetics in 1990, obtained a M.S. in Tumor Cell Biology from Northwestern University Medical School, and later finished his Ph.D. in Developmental Biology at Washington University Medical School.

Roger Song, MBA

Roger Song is an Equity Research Associate with a well-known investment bank on Wall Street and he covers biopharmaceutical and medical devices industries. Bringing nearly a decade of life science industry experience, he focuses on small and mid-cap biopharmaceutical companies which are in pre-IPO or post-IPO process. Before this, Roger held positions in investment, strategy, consulting, marketing and technology sales in several industry-leading companies. Roger holds a master's degree in business administration (MBA) and a degree in clinical medicine. He has passed CFA Level 3 exam.

Share with friends

Date and Time

Location

E51, MIT Campus

70 Memorial Drive

Cambridge, MA 02142

View Map

Save This Event

Event Saved